Yonehiro Grant
Chief Operating Officer
Yonehiro Grant has filed 2 SEC Form 4 filings (4 transaction rows) across 1 company, with disclosures dating back to 2025. 2 of those filings fall inside the rolling window. Most recent filing: Sep 21, 2026.
On the most recent filing, Yonehiro Grant is listed as Chief Operating Officer at Bolt Biotherapeutics, Inc. Inside the rolling window, Yonehiro Grant reported no open-market purchases and 3 open-market sales totaling $44K in BOLT. The largest disclosed transaction in the window is a sale of 6,850 BOLT shares on Sep 18, 2026, worth $22K.
Companies traded
Other insiders at BOLT
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$44K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Yonehiro Grant made?
Yonehiro Grant has filed 2 SEC Form 4 filings (4 transaction rows) across 1 company since 2025.
Which companies does Yonehiro Grant trade?
Yonehiro Grant has filed SEC Form 4 disclosures for 1 company, including BOLT.
When was Yonehiro Grant's most recent SEC Form 4 filing?
Yonehiro Grant's most recent SEC Form 4 filing on Tracefour is dated Sep 21, 2026.
What is Yonehiro Grant's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Yonehiro Grant is listed as Chief Operating Officer.
What is Yonehiro Grant's total buy and sell value in the current window?
Inside the rolling retention window, Yonehiro Grant bought $0 and sold $44K based on SEC Form 4 filings.
What was Yonehiro Grant's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 6,850 BOLT shares on 2026-09-18, worth $22K, per SEC Form 4 filings.